Skip to content

Arcus Capital Partners, LLC: ACWX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Arcus Capital Partners, LLC on ACWX, newest first. How the timeline and the estimate are built.

Arcus Capital Partners, LLC held 131,881 ACWX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 131,881 shares
    Change vs previous 13F +45,685 shares

    4.15% of the 13F portfolio, value $10,037,439.

    13F-HR 0001651960-26-000004 filed by Arcus Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 86,196 shares
    Change vs previous 13F -1,616 shares

    2.12% of the 13F portfolio, value $5,901,874.

    13F-HR 0001651960-26-000003 filed by Arcus Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 87,812 shares
    Change vs previous 13F +72,564 shares

    2.12% of the 13F portfolio, value $5,894,836.

    13F-HR 0001651960-26-000002 filed by Arcus Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 15,248 shares
    Change vs previous 13F +2,356 shares

    0.43% of the 13F portfolio, value $991,273.

    13F-HR 0001651960-25-000005 filed by Arcus Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 12,892 shares
    Change vs previous 13F not available

    0.34% of the 13F portfolio, value $785,639.

    13F-HR 0001651960-25-000003 filed by Arcus Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).